Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|August 11, 2020
Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfectionLorenza N C Dezanet, Sarah Maylin, Audrey Gabassi, et al.
Journal of Medical Virology|October 4, 2024
Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV-1 infected patients in 2020-2023Marie-Laure Chaix, Laura Terracol, Marie-Laure Nere, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-upCorinne Castelnau, Frédéric Le Gal, Marie-Pierre Ripault, et al.
Open Forum Infectious Diseases|July 6, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero CohortsConstance Delaugerre, Lambert Assoumou, Sarah Maylin, et al.
The American Journal of Tropical Medicine and Hygiene|June 6, 2018
Poor Sensitivity of Commercial Rapid Diagnostic Tests for Hepatitis B e Antigen in Senegal, West AfricaAbdoulaye Seck, Fatou Ndiaye, Sarah Maylin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 17, 2008
Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibodySarah Maylin, Michelle Martinot-Peignoux, Marie-Pierre Ripault, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 2, 2019
Hepatitis B virus activity in untreated hepatitis B e antigen-negative human immunodeficiency virus-hepatitis B virus co-infected patients from sub-Saharan AfricaAnders Boyd, Menan Gerard Kouamé, Laura Houghtaling, et al.
Hepatology (Baltimore, Md.)|January 14, 2010
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirinMichelle Martinot-Peignoux, Christiane Stern, Sarah Maylin, et al.
Antiviral Therapy|July 7, 2009
Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirinMichelle Martinot-Peignoux, Sarah Maylin, Rami Moucari, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 24, 2017
Hepatitis B Virus-Hepatitis D Virus mother-to-child co-transmission: A retrospective study in a developed countryPierre O Sellier, Sarah Maylin, Ségolène Brichler, et al.
Pageof 8